Balaji Amines Ltd

NSE
BALAMINES •
BUY

1W Return

-%

1M Return

-%

6M Return

-%

1Y Return

-%

3Y Return

-%

Start SIP in Balaji Amines Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
52W Low on May 22, 2023
11.7
TTM PE Ratio
Above industry Median
39.9
Price to Book Ratio
Below industry Median
4.3
Dividend yield 1yr %
Above industry Median
0.4
TTM PEG Ratio
PEG TTM is negative
-0.7
RSI
RSI is mid-range
45.5
MFI
MFI is mid-range
54.4

Balaji Amines Ltd Key Financials

*All values are in ₹ Cr.

Balaji Amines Ltd shareholding Pattern

Promoter
53.7%
Foreign Institutions
4.6%
Mutual Funds
0.1%
Domestic Institutions
1.4%
Public
40.3%

Balaji Amines Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
4
Bearish Moving Averages
12
5Day EMA
2,273.30
10Day EMA
2,268.30
12Day EMA
2,271.30
20Day EMA
2,293.00
26Day EMA
2,307.30
50Day EMA
2,320.90
100Day EMA
2,296.20
200Day EMA
2,313.10
Delivery & Volume
Resistance & Support
2,276.18
Pivot
Resistance
First Resistance
2,292.37
Second Resistance
2,316.88
Third Resistance
2,333.07
Support
First Support
2,251.67
Second support
2,235.48
Third Support
2,210.97
Relative Strength Index
45.48
Money Flow Index
54.43
MACD
-35.94
MACD Signal
-44.89
Average True Range
79.19
Average Directional Index
15.36
Rate of Change (21)
-3.92
Rate of Change (125)
8.50

Balaji Amines Ltd Company background

Founded in: 1988
Managing director: N Rajeshwar Reddy
Promoted by the KPR Group of Industries, Balaji Amines Ltd. (BAL) was incorporated on 27th October, 1988. The Company is a leading manufacturer of ethyl and methyl amines which have various applications in chemical industries. It is presently engaged in manufacture and sale of Speciality Chemicals, Aliphatic Amines and Derivatives. Apart from this, it has now diversified into producing derivatives of methyl and ethyl amines, namely, DiMethyl Amine Hydrochloride (DMAHCl), Choline Chloride, Di Methyl Acetamide, etc. At present, the Company supply to various Blue Chip Companies like IDI, Hoechst, Rallis, Ion Exchange, Cheminor Drugs, TTK Pharma, etc. It has four manufacturing facilities, three plants at Tuljapur and Chincholi in Maharashtra and one at Medak, Telangana. It owns a Five Star Hotel in Solapur, Maharashtra and has CFL lamps facility at Medak, Telangana. The Company presently operates in three segments i.e., Specialty Chemicals and Amines, Hotel and CFL Lamps. A new facility for manufacture of Speciality Chemicals is under construction at Chicholi, Maharashtra.On May 95, it came out with a public issue of 9.63 lac equity shares (premium : Rs 30), aggregating Rs 3.85 cr to partfinance expansion plans for ethylamines and forward integration for the manufacture of derivatives of methyl and ethyl amines, totaling to Rs 10 cr. In 1988, the Company started business operations.In 1989, it started to produce Methyl Amines and Ethyl Amines.In 1992, the Company established RD Centre at Hyderabad.In 1995, it started manufacturing drug intermediate Dimethyl Amine Hydrochloride.In 199798, the company has successfully commenced the commercial operation of its main plant (Ethyl Amines) from June, 1997.In 2000, it added derivatives of Methyl and Ethyle Amines to the product portfolio.In 2001, the Company was certified with ISO:9001.Expansion programme has been taken up for valueadded products like Choline Chloride, DMAEHCI and other intermediates at a cost of Rs.500 lacs. The project has been appraised by State Bank of Hyderabad and Bank of India for a term loan of Rs.290 lacs and Rs.100 lacs respectively.The balance would be met out by the internal accruals of the company.The project would be implemented on phases and the first phase is likely to be commissioned during the current year 20012002.During the year 2003, Company was awarded Recognized Export House status from Government of India, Ministry of Commerce, New Delhi. It increased the capacity of Methyl Amines.In 2005, the Company developed more specialty chemicals.In 2006, it founded Balaji Foundation and Research Centre for the rural population as a part of CSR activity. It became the sole manufacturerof GBI, NMP, and Morpholine.During the year 2009, the Company started power generation through windmill by establishing 1.5 MW windmill unit at Satara, Maharashtra. It established an R D GBL Plant at Tamalwadi, Solapur. It commenced setting up 2.5 MW CoGeneration Power Plant Unit at Tamalwadi and PVP Plant at Chincholi, in Solapur respectively. Apart from this, it secured the Certificate of Merit for Outstanding Export by Chemexcil.During the year 2010, 2.5 Mw Co Generation Power Plant at Tamalwadi, Solapur has been commissioned in July, 2009. Besides this, the PVP Plant at Chincholi, Solapur has started producing various grades and the mandatory approvals are in final stages.In 2010, the Company installed wind turbine for generating inhouse electricity to start focusing on renewable energy.In 2012, the Company received Certificate of Suitability certification from European Directorate for the Quality Medicines Health Care (EDQM), Europe for its product PVPK30. It also received WHOGMP certification and REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) for four products namely, Triethylamine, Gammabutyrolactone, NEthylamine2Pyrrolidone along with the already registered Nmethyl 2 Pyrrolidone (NMP). It has been awarded for the category of Best Manufacturer Exporter (Medium) at the Indian Exporter Excellence Awards 2012 instituted by the Export Credit Guarantee Corporation of India Limited (ECGC)An Indian Govt. Undertaking, in association with Dun and Bradstreet (DB), which seeks to recognize leading exporters for their excellence in their respective fields. In October 2013, the Company inaugurated its 129 Room FiveStar Hotel Property Balaji Sarovar Premiere with an investment of Rs. 110 crore. It executed the commissioning of DMF manufacturing Plant. Further, two new plants, one for the first phase of DiMethyl Amine Hydrochloride (DMAHCL) with an installed capacity of 7500 MT per annum commissioned in the month of February, 2013 and second plant for manufacture of Di Methyl Formamide (DMF) with an installed capacity of 30000 MT / P. A at MIDC Chincholi, Solapur has been commissioned in the month of March, 2013. During the year 2013, Companys 5 star Hotel Property started commercially from 1st November 2013 which is being managed by Sarovar Group of Hotels.In 2014, the Company was awarded for Balaji Sarovar Premiums ecofriendly Green technology.During the year 2015, Company successfully recommissioned its DMF plant by strengthening the Carbon Monoxide plan. In 2015, it was awarded another Certificate of Excellence for Balaji Sarovar Premiere from the Trip Advisor on the basis of customer reviews for excellent food, service and hospitality.In 2016, it set up a plant to manufacture Acetonitrile.During the year 201718, the subsidiaries of the Company viz. Bhagyanagar Chemicals Limited (companys holding 100%) and Balaji Greentech Products Limited (companys holding 66%) were amalgamated with BAL (the Company) as per the scheme of amalgamation sanctioned by the Honble NCLT, Mumbai.In 2018, the Company was 90 acres of land at MIDC, Chincholi with Mega Project Status for this new project by Maharashtra State Government. It commissioned a new plant for manufacture of Morpholine and Acetonitrile after successful trial runs.In 2019, the Company set up a new plant project under its subsidiary, Balaji Specialty Chemicals Private Limited, which got completed in a record 12 months. In 2021, Company commenced operation in Greenfield Project at UnitIV. The Boiler of 50 TPH capacity was commissioned during FY 202122, with a capex of Rs 19.76 Crores. The Company commissioned a New Ethylamines Plant Phase I of its Greenfield Project. During FY 23, the Company commissioned Phase I (Unit IV) DMC, PG and PC plants, comprising the production capacity of 15,000 tons of Dimethyl Carbonate (DMC)/ Propylene Carbonate (PC) and 15,000 tons of Propylene Glycol (PG).
Read More

Balaji Amines Ltd FAQs

Balaji Amines Ltd shares are currently priced at 2267.85 on NSE and 2265.8 on BSE as of 2/21/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Balaji Amines Ltd [BALAMINES] share was 4.39. The Balaji Amines Ltd [BALAMINES] share hit a 1-year low of Rs. 1880 and a 1-year high of Rs. 2735.

The market cap of Balaji Amines Ltd is Rs. 7348.06 Cr. as of 2/21/2024 12:00:00 AM.

The PE ratios of Balaji Amines Ltd is 50.14 as of 2/21/2024 12:00:00 AM.

The PB ratios of Balaji Amines Ltd is 5.11 as of 2/21/2024 12:00:00 AM

The Mutual Fund Shareholding was 0.07% at the end of 2/21/2024 12:00:00 AM.

You can easily buy Balaji Amines Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage